Study of Alendronate to Prevent and Treat Osteoporosis in Cystic Fibrosis Patients
Condition(s):Cystic Fibrosis; Osteoporosis; Bone Diseases, MetabolicLast Updated:October 23, 2008Completed
Hide Studies Not Open or Pending
Condition(s):Cystic Fibrosis; Osteoporosis; Bone Diseases, MetabolicLast Updated:October 23, 2008Completed
Condition(s):Osteopenia or OsteoprosisLast Updated:October 29, 2020Completed
Condition(s):Metabolic Bone Disease; Transplant-Related Disorder; Secondary OsteoporosisLast Updated:May 6, 2023Completed
Condition(s):Intestinal Failure; Osteoporosis; Metabolic Bone DiseaseLast Updated:January 16, 2024Completed
Condition(s):Kidney Failure, Chronic; Anemia; Vitamin D Deficiency; Bone Diseases, MetabolicLast Updated:August 31, 2018Completed
Condition(s):Metabolic and Nutritional Complications; Protein Malnutrition; Intestinal Malabsorptive Syndrome; Metabolic Bone DiseaseLast Updated:January 1, 2010Completed
Condition(s):Hypopituitarism; Hypogonadism; Thyroid Dysfunction; Bone Diseases, MetabolicLast Updated:December 3, 2018Terminated
Condition(s):Nonalcoholic Fatty Liver; Osteoporosis, PostmenopausalLast Updated:July 28, 2023Recruiting
Condition(s):Connective Tissue Disorders; Osteogenesis Imperfecta; Bone Diseases, Metabolic; MelorheostosisLast Updated:February 2, 2024Completed
Condition(s):Cancer; Inflammatory Disease; Vascular Diseases; Metabolic Bone DiseaseLast Updated:November 1, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.